The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam
Article first published online: 8 FEB 2012
© 2011 The Authors, Addiction © 2011 Society for the Study of Addiction
Volume 107, Issue 3, pages 614–623, March 2012
How to Cite
Matser, A., Urbanus, A., Geskus, R., Kretzschmar, M., Xiridou, M., Buster, M., Coutinho, R. and Prins, M. (2012), The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam. Addiction, 107: 614–623. doi: 10.1111/j.1360-0443.2011.03654.x
- Issue published online: 8 FEB 2012
- Article first published online: 8 FEB 2012
- Accepted manuscript online: 15 SEP 2011 11:23AM EST
- Submitted 6 January 2011; initial review completed 4 March 2011; final version accepted 9 September 2011
Appendix S1 Extensive description of the Markov model to estimate the burden of hepatitis C.
Appendix S2 The population size of injecting drug users in Amsterdam, the Netherlands.
Appendix S3 Sensitivity analysis.
|ADD_3654_sm_Appendix1.ps||749K||Supporting info item|
|ADD_3654_sm_Appendix2.ps||334K||Supporting info item|
|ADD_3654_sm_Appendix3.ps||376K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.